Deerfield Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Deerfield Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,600,000	Closed	-$16.4M	–	112
2023 Q2	$16.4M	Hold	1,600,000	–	–	0.35%	54
2023 Q1	$16.2M	Hold	1,600,000	–	–	0.36%	59
2022 Q4	$16M	Hold	1,600,000	–	–	0.33%	65
2022 Q3	$15.6M	Hold	1,600,000	–	–	0.31%	70
2022 Q2	$15.5M	Hold	1,600,000	–	–	0.32%	69
2022 Q1	$15.5M	Hold	1,600,000	–	–	0.35%	57
2021 Q4	$15.7M	Hold	1,600,000	–	–	0.33%	68
2021 Q3	$15.7M	Buy	+1,600,000	New	+$15.8M	0.31%	79

Deerfield Management's DALS Position: Q3 2023 in Review

Deerfield Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 1,600,000 shares — an estimated $16.4M sold.

Deerfield Management first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $16.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Deerfield Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Deerfield Management sold 1,600,000 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $16.4M.
Deerfield Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
Deerfield Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $16.4M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Deerfield Management's 13F filing for Q3 2023, filed 14 Nov 2023.